The 2^nd China Vaccinology Integrated Innovation & Teaching Development Conference: Promoting the construction of vaccinology discipline system

References

• Pei S. Review of vaccines and immunization by Chuanxi Fu (editor-in-chief). Hum Vaccin Immunother. 2021;17(6):1785–8. doi:10.1080/21645515.2020.1835337.
   Web of Science ®Google Scholar
• Wei Z, Liu Y, Zhang L, Sun X, Jiang Q, Li Z, Wu Y, Fu C. Stages of HPV vaccine hesitancy among guardians of female secondary school students in China. J Adolesc Health. 2023;72(1):73–9. doi:10.1016/j.jadohealth.2022.08.027.
   PubMed Web of Science ®Google Scholar
• Wei Z, Sun X, Yang Y, Zhan S, Fu C. Seasonal influenza vaccine hesitancy profiles and determinants among Chinese children’s guardians and the elderly. Expert Rev Vaccines. 2021;20(5):601–10. doi:10.1080/14760584.2021.1908134.
   PubMed Web of Science ®Google Scholar
• Pizza M, Pecetta S, Rappuoli R. Vaccines 2020: the era of the digital vaccine is here. Sci Transl Med. 2021;13(624):3249. doi:10.1126/scitranslmed.abm3249.
   Web of Science ®Google Scholar
• Rappuoli R, Bottomley MJ, D’oro U, Finco O, De Gregorio E. 2016. Reverse vaccinology 2.0: human immunology instructs vaccine antigen design. J Exp Med. 213(4):469–81. doi: 10.1084/jem.20151960.
   PubMed Web of Science ®Google Scholar
• Dormitzer PR, Grandi G, Rappuoli R. Structural vaccinology starts to deliver. Nat Rev Microbiol. 2012;10(12):807–813. doi:10.1038/nrmicro2893.
   PubMed Web of Science ®Google Scholar
• Fagherazzi G, Goetzinger C, Rashid MA, Aguayo GA, Huiart L. 2020. Digital health strategies to fight COVID-19 worldwide: challenges, recommendations, and a call for papers. J Med Internet Res. 22(6):e19284. doi: 10.2196/19284.
   PubMed Web of Science ®Google Scholar
• The Editors of The Lancet. Retraction–Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children [J]. Lancet. 2010;375(9713):445. doi:10.1016/s0140-6736(10)60175-4.
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Wyka K, M WT, Picchio CA, Gostin LO, Larson HJ, Rabin K, Ratzan SC, Kamarulzaman A, El-Mohandes A. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023;29(2):366–75. doi:10.1038/s41591-022-02185-4.
   PubMed Web of Science ®Google Scholar
• De Figueiredo A, Larson HJ. Exploratory study of the global intent to accept COVID-19 vaccinations. Commun Med. 2021;1(1):30. doi:10.1038/s43856-021-00027-x.
   PubMedGoogle Scholar
• Chen L, Li Z, Lu X, Deng Y, Lu K, Li T, Lu L, Wang Z, Lu J. Changes in COVID-19 vaccine hesitancy at different times among residents in Guangzhou, China. Front Public Health. 2023;11(1164475). doi: 10.3389/fpubh.2023.1164475.
   Google Scholar
• LW LF. Vaccines and health. Wuhan (China): Wuhan Universuty Press; 2022.
   Google Scholar
• Organization (Who) W H. Implementing the immunization agenda 2030. 2021.
   Google Scholar
• Kaur G, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, Sodha SV, Sugerman C, Wallace A. Routine vaccination coverage — worldwide, 2022. MMWR Morb Mortal Wkly Rep. 2023;72(43):1155–61. doi:10.15585/mmwr.mm7243a1.
   PubMedGoogle Scholar
• Bussink-Voorend D, Hautvast JLA, Vandeberg L, Visser O, Hulscher MEJL. A systematic literature review to clarify the concept of vaccine hesitancy. Nat Hum Behav. 2022;6(12):1634–48. doi:10.1038/s41562-022-01431-6.
   PubMed Web of Science ®Google Scholar
• Macdonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Tram KH, Saeed S, Bradley C, Fox B, Eshun-Wilson I, Mody A, Geng E. 2022. Deliberation, dissent, and distrust: understanding distinct drivers of coronavirus disease 2019 vaccine hesitancy in the United States. Clin Infect Dis. 74(8):1429–41. doi: 10.1093/cid/ciab633.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhao T, Wang L, Yang Z, Luo C, Li M, Luo H, Sun C, Yan H, Shu Y, et al. A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses. NPJ Vaccines. 2023;8(1):132. doi:10.1038/s41541-023-00728-5.
   PubMed Web of Science ®Google Scholar
• Yuan L, Li X, Li M, Bi R, Li Y, Song J, Li W, Yan M, Luo H, Sun C, et al. In silico design of a broad-spectrum multiepitope vaccine against influenza virus. Int J Biol Macromol. 2023;254(Pt 3):128071. doi:10.1016/j.ijbiomac.2023.128071.
   PubMedGoogle Scholar
• Wang R, Han Y, Zhang R, Zhu J, Nan X, Liu Y, Yang Z, Zhou B, Yu J, Lin Z, et al. Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infection. Immunity. 2023;56(11):2635–49. doi:10.1016/j.immuni.2023.10.007.
   PubMed Web of Science ®Google Scholar
• Li M, Ren Y, Q AZ, Chen B, Yang Z, Lei Y, Cheng L, Liang Q, Hong J, Yang Y, et al. Broadly neutralizing and protective nanobodies against SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses. Nat Commun. 2022;13(1):7957. doi:10.1038/s41467-022-35642-2.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu S, Liu J, Chen R, Zhang Y, Lin Y, Xi Z, Deng J, Pu Z, Liang C, et al. A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross-Protection Activity against Multiple SARS-CoV-2 Sublineages. Adv Sci. 2023;10(27):e2301034. Weinheim, Baden-Wurttemberg, Germany. doi:10.1002/advs.202301034.
   Web of Science ®Google Scholar
• Lu F, Xu C, Zhang P, Xu Y, Liu J. Construction and implementation of big data in healthcare in Yichang City, Hubei Province. China CDC Weekly. 2021;3(1):14–17. doi:10.46234/ccdcw2020.254.
   PubMedGoogle Scholar
• Zhu A, Liu J, Ye C, Yu J, Peng Z, Feng L, Wang L, Qin Y, Zheng Y, Li Z, et al. Characteristics of seasonal influenza virus activity in a subtropical city in China, 2013–2019. Vaccines. 2020;8(1):108. doi:10.3390/vaccines8010108.
   Web of Science ®Google Scholar
• Li Y, Liu J, Yang Z, Yu J, Xu C, Zhu A, Zhang H, Yang X, Zhao X, Ren M, et al. Transmission of severe acute respiratory syndrome coronavirus 2 to close contacts, China, January–February 2020. Emerg Infect Dis. 2021;27(9):2288–93. doi:10.3201/eid2709.202035.
   PubMed Web of Science ®Google Scholar
• Das M. WHO launches strategy to accelerate elimination of cervical cancer. Lancet Oncol. 2021;22(1):20–21. doi:10.1016/s1470-2045(20)30729-4.
   PubMed Web of Science ®Google Scholar
• Yuan MW, Wang HH, Duan RF, Xu KP, Hu SY, Qiao YL, Zhang Y, Zhao F. Analysis on cancer incidence and mortality attributed to human papillomavirus infection in China, 2016]. Zhonghua liu xing bing xue za zhi = zhonghua liuxingbingxue zazhi. 2022;43(5):702–8. doi:10.3760/cma.j.cn112338-20211010-00777.
   PubMedGoogle Scholar
• Ding W, Ma Y, Ma C, Malone DC, Ma A, Tang W, Si L. The lifetime cost estimation of human papillomavirus-related diseases in China: a modeling study. J Transl Intern Med. 2021;9(3):200–11. doi:10.2478/jtim-2021-0039.
   PubMed Web of Science ®Google Scholar
• Wu Q, Jia M, Chen H, Zhang S, Liu Y, Prem K, Qian M, Yu H. The economic burden of cervical cancer from diagnosis to one year after final discharge in Henan Province, China: a retrospective case series study. PLoS One. 2020;15(5):e0232129. doi:10.1371/journal.pone.0232129.
   PubMed Web of Science ®Google Scholar
• Diakite I, Kyle J, Situ S, Bai P, Zhang X, Wang W, Daniels V. Public health impact of 2-, 4-, and 9-valent HPV vaccination in females on cervical and noncervical diseases in men and women under different coverage scenarios in China: a simulation study. Hum Vaccin Immunother. 2023;19(2):2258569. doi:10.1080/21645515.2023.2258569.
   PubMed Web of Science ®Google Scholar
• Xia C, Xu X, Zhao X, Hu S, Qiao Y, Zhang Y, Hutubessy R, Basu P, Broutet N, Jit M, et al. Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study. BMC Med. 2021;19(1):62. doi:10.1186/s12916-021-01930-9.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang Z, Zhang X, Xu C, Song Y, Li L, Ye J, Wang Z, Liang H, Zhang W, et al. Coverage of 13-valent pneumococcal conjugate vaccine among children 0–15 months of age – 9 provinces, China, 2019–2021. China CDC Weekly. 2023;5(17):379–84. doi:10.46234/ccdcw2023.072.
   PubMedGoogle Scholar
• Maman K, Zöllner Y, Greco D, Duru G, Sendyona S, Remy V. The value of childhood combination vaccines: from beliefs to evidence. Hum Vaccin Immunother. 2015;11(9):2132–2141. doi:10.1080/21645515.2015.1044180.
   PubMed Web of Science ®Google Scholar
• Ma J, Li Z, Sun Y, Liu Z, Dang Y, Huang Y. Improving innovation and access to combination vaccines for childhood immunization in China. Int J Env Res Pub He. 2022;19(23):15557. doi:10.3390/ijerph192315557.
   PubMed Web of Science ®Google Scholar
• You Y, Li X, Jiang S, Liang J, Xie P, Zou X, Liu G, Han X. Can primary care physician recommendation improve influenza vaccine uptake among older adults? A community health centre-based experimental study in China. BMC Primary Care. 2023;24(1):16. doi:10.1186/s12875-023-01980-3.
   PubMedGoogle Scholar
• You Y, Li X, Chen B, Zou X, Liu G, Han X. Knowledge, attitude, and practice towards influenza vaccination among older adults in southern China during the COVID-19 pandemic. Vaccines. 2023;11(7):1197. doi:10.3390/vaccines11071197.
   Web of Science ®Google Scholar
• Chinese Preventive Medicine Association Task Force on the Methodology of Real-World Studies on Influenza Vaccine Effectiveness S, Y.Feng Z, Jiang Y. Expert consensus on methodology for real-world studies of influenza vaccine effectivenes. Chinese J Vaccines Immun. 2022;28(6):617–637. doi:10.19914/j.CJVI.2022118.
   Google Scholar
• Ren Y, Wang N, Hu W, Zhang X, Xu J, Wan Y. Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination. Sci Rep. 2015;5(1). doi: 10.1038/srep18099.
   Google Scholar
• Tian X, Zhang Y, He Z, Li S, Yan D, Zhu Z, Wan Y, Wang W. 2022. Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein. Front Immunol. 13:875236. doi: 10.3389/fimmu.2022.875236.
   PubMed Web of Science ®Google Scholar
• Liu J, Chandrashekar A, Sellers D, Barrett J, Jacob-Dolan C, Lifton M, McMahan K, Sciacca M, VanWyk H, Wu C, et al. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 omicron. Nature. 2022;603(7901):493–496. doi:10.1038/s41586-022-04465-y.
   PubMed Web of Science ®Google Scholar
• Collier AY, Yu J, Mcmahan K, Liu J, Chandrashekar A, Maron JS, Atyeo C, Martinez DR, Ansel JL, Aguayo R, et al. Differential kinetics of immune responses elicited by covid-19 vaccines. N Engl J Med. 2021;385(21):2010–2. doi:10.1056/NEJMc2115596.
   PubMed Web of Science ®Google Scholar
• Liu J, Yu J, Mcmahan K, Jacob-Dolan C, He X, Giffin V, Wu C, Sciacca M, Powers O, Nampanya F, et al. CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques. Sci Immunol. 2022;7(77):eabq7647. doi:10.1126/sciimmunol.abq7647.
   PubMed Web of Science ®Google Scholar
• He B, Liu S, Wang Y, Xu M, Cai W, Liu J, Bai W, Ye S, Ma Y, Hu H, et al. Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq. Signal Transduct Target Ther. 2021;6(1):195. doi:10.1038/s41392-021-00610-7.
   PubMed Web of Science ®Google Scholar
• He B, Liu S, Xu M, Hu Y, Lv K, Wang Y, Ma Y, Zhai Y, Yue X, Liu L, et al. Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing. Emerg Microbes Infect. 2022;11(1):2007–2020. doi:10.1080/22221751.2022.2105261.
   PubMed Web of Science ®Google Scholar
• Yang J, Q LM, Liu L, Li X, Xu M, Lin H, Liu S, Hu Y, Li B, Liu B, et al. A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern. Cell Mol Immunol. 2022;19(11):1279–89. doi:10.1038/s41423-022-00929-3.
   PubMed Web of Science ®Google Scholar
• Laupèze B, Hervé C, Di Pasquale A, Tavares Da Silva F. Adjuvant systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood. Vaccine. 2019;37(38):5670–80. doi:10.1016/j.vaccine.2019.07.098.
   PubMed Web of Science ®Google Scholar
• Guy B. The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol. 2007;5(7):505–17. doi:10.1038/nrmicro1681.
   PubMed Web of Science ®Google Scholar
• Gao L, Li Y, He P, Chen Z, Yang H, Li F, Zhang S, Wang D, Wang G, Yang S, et al. 2023. Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial. Lancet Child Adolesc Health. 7(4):269–79. doi: 10.1016/s2352-4642(22)00376-5.
   PubMedGoogle Scholar
• Huang X, Liang C, Li M, Chen H, Li Z, Ruan Q, Hu X, Zeng L, Lin H, Zhao W, et al. Refocus on immunogenic characteristics of convalescent COVID-19 challenged by prototype SARS-CoV-2. Vaccines. 2023;11(1):123. doi:10.3390/vaccines11010123.
   Web of Science ®Google Scholar
• Zhang G, Cong Y, Liu LF, Sun J, Zhang J, Cao G, Zhou L, Yang W, Song Q, Wang F, et al. A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination. Nat Nanotechnol. 2022;17(9):993–1003. doi:10.1038/s41565-022-01177-2.
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhang J. Surveillance on other infectious diarrheal diseases in China from 2014 to 2015. Chin J Epidemiol. 2017;4:424–30.
   Google Scholar
• Who. Rotavirus vaccines in routine immunization. Pocket Guide. 2012.
   Google Scholar
• Burke RM, Tate JE, Parashar UD. Global Experience With Rotavirus Vaccines. J Infect Dis. 2021;224(12 Suppl 2):S792–S800. doi:10.1093/infdis/jiab399.
   PubMedGoogle Scholar
• Burnett E, Tate JE, Kirkwood CD, Nelson, EA, Santosham, M, Steele, AD, Parashar, UD. 2018. Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia. Expert Rev Vaccines. 17(5):453–60. doi: 10.1080/14760584.2018.1443008.
   PubMed Web of Science ®Google Scholar
• Yu J, Lai S, Geng Q, Ye C, Zhang Z, Zheng Y, Wang L, Duan Z, Zhang J, Wu S, et al. Prevalence of rotavirus and rapid changes in circulating rotavirus strains among children with acute diarrhea in China, 2009–2015. J Infect. 2019;78(1):66–74. doi:10.1016/j.jinf.2018.07.004.
   PubMed Web of Science ®Google Scholar
• Mo Z, Ma X, Luo P, Mo Y, Kaplan SS, Shou Q, Zheng M, Hille DA, Arnold BA, Liao X, et al. Immunogenicity of pentavalent rotavirus vaccine in Chinese infants. Vaccine. 2019;37(13):1836–1843. doi:10.1016/j.vaccine.2019.02.018.
   PubMed Web of Science ®Google Scholar
• Feng F, Hao H, Zhao J, Li Y, Zhang Y, Li R, Wen Z, Wu C, Li M, Li P, et al. Shell-mediated phagocytosis to reshape viral-vectored vaccine-induced immunity. Biomaterials. 2021;276(121062):121062. doi:10.1016/j.biomaterials.2021.121062.
   PubMedGoogle Scholar
• Feng F, Wen Z, Chen J, Yuan Y, Wang C, Sun C. Strategies to develop a mucosa-targeting vaccine against emerging infectious diseases. Viruses. 2022;14(3):520. doi:10.3390/v14030520.
   PubMed Web of Science ®Google Scholar
• Li M, Yang L, Wang C, Cui M, Wen Z, Liao Z, Han Z, Zhao Y, Lang B, Chen H, et al. Rapid induction of long-lasting systemic and mucosal immunity via Thermostable Microneedle-Mediated Chitosan Oligosaccharide-Encapsulated DNA Nanoparticles. Acs Nano. 2023;17(23):24200–24217. doi:10.1021/acsnano.3c09521.
   PubMedGoogle Scholar